Joseph T. Morrissey Jr. - 13 Nov 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Interim CEO
Signature
/s/ Faye C. Brown, as Attorney-in-Fact for Joseph T. Morrissey, Jr.
Issuer symbol
OGN
Transactions as of
13 Nov 2025
Net transactions value
$0
Form type
4
Filing time
17 Nov 2025, 16:04:18 UTC
Previous filing
02 Apr 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morrissey Joseph T. Jr. Interim CEO C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY /s/ Faye C. Brown, as Attorney-in-Fact for Joseph T. Morrissey, Jr. 17 Nov 2025 0001859805

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Award $0 +131,233 $0.000000 131,233 13 Nov 2025 Common Stock 131,233 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") converts into one share of Organon & Co. ("Organon") common stock.
F2 The Reporting Person was granted RSUs on November 13, 2025 (which was the close of business on the third business day following the release of Organon's earnings for the quarter ended September 30, 2025, on November 10, 2025). These RSUs vest and become exercisable in three equal installments on November 13, 2026, November 13, 2027, and November 13, 2028.

Remarks:

Exhibit 24 - Power of Attorney